Affordable Access

Primary drug resistance to both rifampicin and dapsone in a paucibacillary leprosy patient.

Authors
Type
Published Article
Journal
Indian journal of leprosy
Publication Date
Volume
60
Issue
1
Pages
90–92
Identifiers
PMID: 3060548
Source
Medline
License
Unknown

Abstract

A thirty-one year old male patient was diagnosed and treated for a pure or better primary neuritic case of leprosy with dapsone (100 mg daily for 2 years) and rifampicin (600 mg daily for 6 months). From the very outset, the patient did not show any improvement; on the top of it, he subsequently, developed a cutaneous patch, which on histopathological examination, revealed classical features of BT leprosy. Acid-fast bacilli were absent both in skin slit smear and histologic section. A primary resistance to both dapsone and rifampicin, even in paucibacillary patient, is speculated.

Statistics

Seen <100 times